Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study

Abstract

Few studies have investigated whether ethnic groups differ in the prevalence of peripheral arterial disease (PAD). We compared the distribution of the ankle-brachial index (ABI), a measure of PAD, between African Americans and non-Hispanic white individuals. Subjects (n = 931) belonged to the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a community-based study of hypertensive sibships, and included 453 African Americans from Jackson, Mississipi (mean age 72 6 years, 69% women) and 478 non-Hispanic white individuals from Rochester, Minnesota (mean age 58 7 years, 64% women). ABI was determined at two sites in each lower extremity and the lowest of four indices was used in the analyses. PAD was defined as an ABI of 0.95. Information about conventional risk factors was derived from interviews and from blood samples drawn at the study visit. The prevalence of diabetes and hypertension was significantly higher in African Americans than in non-Hispanic white individuals. After adjusting for age, African American subjects had a lower mean ABI (women 0.97 vs 1.04, p < 0.001; men 0.96 vs 1.12, p < 0.001) and a greater prevalence of PAD (women 34% vs 22%, p = 0.010; men 33% vs 11%, p < 0.001) than their non-Hispanic white counterparts. In multiple regression analyses, African American ethnicity was a predictor of a lower ABI and the presence of PAD in each sex after adjusting for age and other conventional risk factors. In conclusion, the lower ABI and greater prevalence of PAD in African Americans than in non-Hispanic white individuals is not explained by differences in conventional risk factors. Identifying additional ‘novel’ risk factors that account for the ethnic differences in PAD is an important next step towards understanding why such differences exist and developing more effective strategies to reduce the burden of PAD.

Keywords

ankle-brachial index ethnicity peripheral arterial disease risk factors

References

Hiatt WR , Hoag S , Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91: 1472-1479.

Criqui MH. Peripheral arterial disease-epidemiological aspects. Vasc Med 2001; 6: 3-7.

Kannel WB , McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13-18.

Vogt MT , Cauley JA , Newman AB , Kuller LH , Hulley SB , Sutton-Tyrrell K. Decreased ankle=arm blood pressure index and mortality in elderly women. JAM A 1993; 270: 465-469.

Newman AB , Sutton-Tyrrell K , Vogt MT , Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle=arm blood pressure index. JAM A 1993; 270: 487-489.

Muller-Buhl U , Wiesemann A , Oser B , Kirchberger I , Strecker EP. Correlation of hemodynamic and functional variables with the angio-graphic extent of peripheral arterial occlusive disease. Vasc M ed 1999; 4: 247-251.

Murabito JM , Evans JC , Nieto K , Larson MG , Levy D , Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002; 143: 961-965.

Murabito JM , D’Agostino RB , Silbershatz H , Wilson PWF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 1997; 96: 44-49.

Fowkes FG , Housley E , Cawood EH , Macintyre CC , Ruckley CV , Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392.

10.

Lee TC , O’Malley PG , Feuerstein I , Taylor AJ. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in African American and white subjects. J Am Coll Cardiol 2003; 41: 39-44.

11.

Boerwinkle E. Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 2002; 39: 3-9.

12.

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-1621.

13.

Zeger SL , Liang KY. Longitudinaldata analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.

14.

Newman AB , Siscovick DS , Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837-845.

15.

Kuller L , Fisher L , McClelland R et al. Differences in prevalence of and risk factors for subclinical vascular disease among black and white participants in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1998; 18: 283-293.

16.

Zheng ZJ , Sharrett AR , Chambless LE et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 1997; 131: 115-125.

17.

Collins TC , Johnson M , Henderson W , Khuri SF , Daley J.

Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor?

M ed Care 2002; 40: I106-I116.

18.

Freedman DS , Newman WP 3rd , Tracy RE et al. Black-white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study. Circulation 1988; 77: 856-864.

19.

Zheng ZJ , Barnes RW , Chambless LE et al. Lower extremity arterial disease by ankle brachial index in black and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 89(2): P31-P31 (abstract).

20.

Higgins JP , Higgins JA. Epidemiology of peripheral arterial disease in women. J Epidemiol 2003; 13: 1-14.

21.

Wilson PW , D’Agostino RB , Levy D , Belanger AM , Silbershatz H , Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.

22.

Jones DW , Sempos CT , Thom TJ et al. Rising levels of cardiovascular mortality in Mississippi, 1979-1995. Am J M ed Sci 2000; 319: 131-137.